U.S. Health Secretary Robert F. Kennedy Jr. pressured former CDC Director Susan Monarez to approve changes to the childhood vaccination schedule without reviewing scientific evidence, Monarez told a Senate panel Wednesday. She said Kennedy insisted she commit to pre-approving recommendations from the CDC’s vaccine advisory board and fire staff overseeing vaccine policy. Monarez refused, and days later, President Donald Trump dismissed her after just 29 days in the role.
Monarez, a microbiologist and immunologist with nearly two decades of federal service, was the first CDC director confirmed by the Senate. She testified that Kennedy told her “there was no science” supporting the current vaccine schedule and that if she did not comply, she should resign. He also barred her from speaking with Senators. Kennedy, however, denied demanding pre-approval during a Senate Finance Committee hearing earlier this month.
Her ousting triggered the resignation of four senior CDC officials, who cited Kennedy’s anti-vaccine stance and misinformation. Critics, including medical professionals, have called for Kennedy to step down, warning his policies undermine public health. Senator Bill Cassidy, chair of the Senate health committee, said the firing raised questions about why someone with “unimpeachable scientific credentials” was pushed out so quickly.
Kennedy has reshaped the CDC’s vaccine advisory board, replacing all 17 members with 12 new appointees. Experts warn that upcoming votes on childhood vaccines lack the usual scientific rigor, since key work group meetings have not been held. Cassidy cautioned Americans against trusting potential changes to the vaccine schedule. Kennedy has already narrowed eligibility for COVID-19 shots and cut funding for mRNA vaccine research, deepening concerns over U.S. vaccination policy.


Ireland Limits Planned Trade Ban on Israeli Settlements to Goods Only
US Charges Two Men in Alleged Nvidia Chip Smuggling Scheme to China
California, 18 States Sue to Block Trump’s $100,000 H-1B Visa Fee
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
U.S. Homeland Security Ends TSA Union Contract, Prompting Legal Challenge
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
U.S. Lifts Sanctions on Brazilian Supreme Court Justice Amid Shift in Brazil Relations
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
Thousands Protest in Brazil Against Efforts to Reduce Jair Bolsonaro’s Prison Sentence
International Stabilization Force for Gaza Nears Deployment as U.S.-Led Planning Advances
Trump Criticizes EU’s €120 Million Fine on Elon Musk’s X Platform
CFPB to Review Anti-Discrimination Policies and Fair Lending Rules Amid Policy Shift
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
International Outcry Grows Over Re-Arrest of Nobel Laureate Narges Mohammadi in Iran
Trump Criticizes Insurers as Debate Over Extending Obamacare Subsidies Intensifies
U.S. Military Bill Seeks to End Dependence on China for Display Technology by 2030 



